Propanc Biopharma, Inc.

PPCB ·Healthcare, Drug Manufacturers - General, Australia
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
EFFECT Oct 18, 2016
POS AM Oct 6, 2016 POS AM
POS AM Oct 6, 2016 POS AM
10-K Sep 28, 2016 10-K
4 Sep 27, 2016 PRIMARY DOCUMENT
4 Sep 27, 2016 PRIMARY DOCUMENT
424B3 Sep 19, 2016 424B3
424B3 Sep 19, 2016
8-K Sep 16, 2016 FORM 8-K
424B3 Aug 26, 2016 424B3
424B3 Aug 26, 2016 424B3
8-K Aug 23, 2016 FORM 8-K
S-1 Aug 19, 2016 S-1
424B3 Aug 4, 2016 424B3
424B3 Aug 4, 2016 424B3
8-K Aug 4, 2016 8-K
424B3 Jul 6, 2016 424B3
424B3 Jul 6, 2016 424B3
8-K Jul 5, 2016 FORM 8-K
8-K May 24, 2016 FORM 8-K
10-Q May 16, 2016 FORM 10-Q
EFFECT Apr 18, 2016
CORRESP Apr 14, 2016
S-1/A Apr 14, 2016 S-1/A
UPLOAD Apr 7, 2016
← Newer Page 14 of 18 · 436 filings Older →